All companies
Visit website
Zendo
OperatingBodhi NeuroTech, Inc.
Healthcare · Founded 2017
Wearable Neuromodulation device that's disrupting the wellness industry
Post-money valuation ⓘ
$10.2M
As of Feb 2023 · from ZENDO Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$85,147
Across 1 round since 2022
Latest share price
$1.00
ZENDO Preferred Stock 1 offering price
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its source$14K
−$124K
2020
$50K
−$107K
2021
$3K
−$78K
2022
$0
−$54K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$13,641
$49,710
$3,000
$0
Cost of goods sold
$10,228
$40,054
$29,779
$0
Gross margin
25%
19%
-893%
—
Net income
-$124,076
-$107,112
-$77,883
-$53,597
Taxes paid
$0
$234
$234
$372
Balance sheet
Cash
$26,081
$160,182
$77,021
$52,903
Accounts receivable
$0
$0
$0
$0
Total assets
$96,483
$195,022
$81,671
$52,903
Short-term debt
$37,436
$43,087
$73,756
$102,893
Long-term debt
$0
$200,000
$200,000
$200,000
Total liabilities
$37,436
$243,087
$273,756
$302,893
Other
Headcount
—
1
0
0
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$10.2M
post-money
ZENDO Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $85.1K / $1.1MInvestors 58Post-money $10.2M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 4 annual reports (FY2022–FY2025)
58 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001952258Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.